Logo image of CRAYN.OL

CRAYON GROUP HOLDING AS (CRAYN.OL) Stock Fundamental Analysis

Europe - OSL:CRAYN - NO0010808892 - Common Stock

144 NOK
-0.5 (-0.35%)
Last: 7/2/2025, 7:00:00 PM
Fundamental Rating

5

Taking everything into account, CRAYN scores 5 out of 10 in our fundamental rating. CRAYN was compared to 111 industry peers in the Software industry. While CRAYN has a great profitability rating, there are quite some concerns on its financial health. CRAYN may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRAYN was profitable.
In the past year CRAYN had a positive cash flow from operations.
Of the past 5 years CRAYN 4 years were profitable.
CRAYN had a positive operating cash flow in each of the past 5 years.
CRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFCRAYN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

CRAYN's Return On Assets of 1.53% is in line compared to the rest of the industry. CRAYN outperforms 55.77% of its industry peers.
With a decent Return On Equity value of 10.80%, CRAYN is doing good in the industry, outperforming 66.35% of the companies in the same industry.
CRAYN has a Return On Invested Capital of 11.88%. This is amongst the best in the industry. CRAYN outperforms 84.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRAYN is below the industry average of 12.56%.
The 3 year average ROIC (8.15%) for CRAYN is below the current ROIC(11.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROIC 11.88%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
CRAYN.OL Yearly ROA, ROE, ROICCRAYN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 -15

1.3 Margins

Looking at the Profit Margin, with a value of 4.12%, CRAYN is in line with its industry, outperforming 55.77% of the companies in the same industry.
CRAYN's Profit Margin has declined in the last couple of years.
CRAYN's Operating Margin of 11.00% is fine compared to the rest of the industry. CRAYN outperforms 66.35% of its industry peers.
In the last couple of years the Operating Margin of CRAYN has grown nicely.
CRAYN's Gross Margin of 89.27% is amongst the best of the industry. CRAYN outperforms 88.46% of its industry peers.
CRAYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11%
PM (TTM) 4.12%
GM 89.27%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
CRAYN.OL Yearly Profit, Operating, Gross MarginsCRAYN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRAYN is creating some value.
Compared to 1 year ago, CRAYN has more shares outstanding
Compared to 5 years ago, CRAYN has more shares outstanding
CRAYN has a better debt/assets ratio than last year.
CRAYN.OL Yearly Shares OutstandingCRAYN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRAYN.OL Yearly Total Debt VS Total AssetsCRAYN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

CRAYN has an Altman-Z score of 1.02. This is a bad value and indicates that CRAYN is not financially healthy and even has some risk of bankruptcy.
CRAYN's Altman-Z score of 1.02 is on the low side compared to the rest of the industry. CRAYN is outperformed by 70.19% of its industry peers.
CRAYN has a debt to FCF ratio of 1.61. This is a very positive value and a sign of high solvency as it would only need 1.61 years to pay back of all of its debts.
CRAYN's Debt to FCF ratio of 1.61 is fine compared to the rest of the industry. CRAYN outperforms 75.96% of its industry peers.
CRAYN has a Debt/Equity ratio of 0.58. This is a neutral value indicating CRAYN is somewhat dependend on debt financing.
CRAYN has a Debt to Equity ratio of 0.58. This is in the lower half of the industry: CRAYN underperforms 62.50% of its industry peers.
Although CRAYN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Altman-Z 1.02
ROIC/WACC1.23
WACC9.67%
CRAYN.OL Yearly LT Debt VS Equity VS FCFCRAYN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.98 indicates that CRAYN may have some problems paying its short term obligations.
With a Current ratio value of 0.98, CRAYN is not doing good in the industry: 67.31% of the companies in the same industry are doing better.
CRAYN has a Quick Ratio of 0.98. This is a bad value and indicates that CRAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CRAYN (0.98) is worse than 66.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
CRAYN.OL Yearly Current Assets VS Current LiabilitesCRAYN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

5

3. Growth

3.1 Past

CRAYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.17%, which is quite impressive.
CRAYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
CRAYN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.67%.
The Revenue for CRAYN have been decreasing by -12.43% on average. This is quite bad
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%

3.2 Future

The Earnings Per Share is expected to grow by 48.55% on average over the next years. This is a very strong growth
Based on estimates for the next years, CRAYN will show a decrease in Revenue. The Revenue will decrease by -1.25% on average per year.
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRAYN.OL Yearly Revenue VS EstimatesCRAYN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
CRAYN.OL Yearly EPS VS EstimatesCRAYN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 35.29, which means the current valuation is very expensive for CRAYN.
74.04% of the companies in the same industry are more expensive than CRAYN, based on the Price/Earnings ratio.
CRAYN's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.40.
A Price/Forward Earnings ratio of 13.49 indicates a correct valuation of CRAYN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRAYN indicates a rather cheap valuation: CRAYN is cheaper than 86.54% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CRAYN to the average of the S&P500 Index (22.94), we can say CRAYN is valued slightly cheaper.
Industry RankSector Rank
PE 35.29
Fwd PE 13.49
CRAYN.OL Price Earnings VS Forward Price EarningsCRAYN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CRAYN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRAYN is cheaper than 73.08% of the companies in the same industry.
91.35% of the companies in the same industry are more expensive than CRAYN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.23
EV/EBITDA 11.79
CRAYN.OL Per share dataCRAYN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

CRAYN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRAYN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CRAYN's earnings are expected to grow with 48.55% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y65.95%
EPS Next 3Y48.55%

0

5. Dividend

5.1 Amount

CRAYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CRAYON GROUP HOLDING AS

OSL:CRAYN (7/2/2025, 7:00:00 PM)

144

-0.5 (-0.35%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-21 2025-05-21/bmo
Earnings (Next)08-27 2025-08-27
Inst Owners59.97%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap12.90B
Analysts76
Price Target144.46 (0.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.25%
Min EPS beat(2)-60.61%
Max EPS beat(2)-37.9%
EPS beat(4)0
Avg EPS beat(4)-35.83%
Min EPS beat(4)-60.61%
Max EPS beat(4)-13.94%
EPS beat(8)2
Avg EPS beat(8)-24.98%
EPS beat(12)2
Avg EPS beat(12)-66.98%
EPS beat(16)5
Avg EPS beat(16)-94.94%
Revenue beat(2)0
Avg Revenue beat(2)-8.54%
Min Revenue beat(2)-9.83%
Max Revenue beat(2)-7.25%
Revenue beat(4)0
Avg Revenue beat(4)-7.68%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)-4.06%
Revenue beat(8)3
Avg Revenue beat(8)-3.98%
Revenue beat(12)5
Avg Revenue beat(12)-13.42%
Revenue beat(16)5
Avg Revenue beat(16)-31.36%
PT rev (1m)0%
PT rev (3m)0.55%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)-1.78%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.11%
Valuation
Industry RankSector Rank
PE 35.29
Fwd PE 13.49
P/S 1.81
P/FCF 11.23
P/OCF 9.75
P/B 4.76
P/tB N/A
EV/EBITDA 11.79
EPS(TTM)4.08
EY2.83%
EPS(NY)10.68
Fwd EY7.41%
FCF(TTM)12.83
FCFY8.91%
OCF(TTM)14.77
OCFY10.26%
SpS79.49
BVpS30.28
TBVpS-11.43
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.53%
ROE 10.8%
ROCE 17.55%
ROIC 11.88%
ROICexc 17.65%
ROICexgc N/A
OM 11%
PM (TTM) 4.12%
GM 89.27%
FCFM 16.14%
ROA(3y)0.27%
ROA(5y)0.94%
ROE(3y)1.7%
ROE(5y)5.34%
ROIC(3y)8.15%
ROIC(5y)8.32%
ROICexc(3y)11.91%
ROICexc(5y)28.33%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.05%
ROCE(5y)12.29%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y22.85%
ROICexc growth 5Y8.87%
OM growth 3Y-1%
OM growth 5Y62.81%
PM growth 3Y-16.95%
PM growth 5YN/A
GM growth 3Y1.37%
GM growth 5Y46.49%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 1.61
Debt/EBITDA 1.4
Cap/Depr 50.58%
Cap/Sales 2.44%
Interest Coverage 250
Cash Conversion 117.39%
Profit Quality 392.15%
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 1.02
F-Score6
WACC9.67%
ROIC/WACC1.23
Cap/Depr(3y)45.9%
Cap/Depr(5y)48.63%
Cap/Sales(3y)2.42%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.17%
EPS 3Y8.95%
EPS 5YN/A
EPS Q2Q%38.61%
EPS Next Y108.12%
EPS Next 2Y65.95%
EPS Next 3Y48.55%
EPS Next 5YN/A
Revenue 1Y (TTM)7.67%
Revenue growth 3Y25.66%
Revenue growth 5Y-12.43%
Sales Q2Q%6.61%
Revenue Next Year13.29%
Revenue Next 2Y13.92%
Revenue Next 3Y13.37%
Revenue Next 5Y-1.25%
EBIT growth 1Y72.09%
EBIT growth 3Y24.41%
EBIT growth 5Y42.57%
EBIT Next Year56.93%
EBIT Next 3Y29.1%
EBIT Next 5YN/A
FCF growth 1Y231.56%
FCF growth 3YN/A
FCF growth 5Y59.47%
OCF growth 1Y165.01%
OCF growth 3Y272.45%
OCF growth 5Y47.49%